Fanhdi

Fanhdi is a medication containing human coagulation factor VIII and von Willebrand factor, used to manage bleeding disorders. This intravenous treatment supports blood clotting and is manufactured by Instituto Grifols, S.A.

Fanhdi is primarily used to treat bleeding episodes in individuals with hemophilia A and von Willebrand disease. It works by replacing the missing clotting factors in the blood, helping to control and prevent bleeding. This medication is often used in situations where rapid clotting is necessary, such as during surgery or after an injury.

Common effects of Fanhdi may include mild reactions at the injection site, such as redness or swelling. Some users might experience flu-like symptoms, including fever or chills. Severe allergic reactions are rare but possible and require immediate medical attention.

Fanhdi should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before use. Proper storage and handling are crucial to maintain the effectiveness of the medication.

Fanhdi may interact with certain medications, including those that affect blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect blood clotting should be used with caution.